Dingal, Pedro .
HRN: 02-99-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2024
09/22/2024
IV
500mg
Q8
H. Pylori Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes